Suppr超能文献

地塞米松通过抑制 11β-羟类固醇脱氢酶 1 和糖皮质激素受体的表达来抑制人冠状动脉平滑肌细胞的体外增殖。

Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.

机构信息

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, NRB 0630 K, Boston, MA 02115, USA.

出版信息

Mol Cell Biochem. 2011 Jan;346(1-2):69-79. doi: 10.1007/s11010-010-0592-5. Epub 2010 Oct 5.

Abstract

The actions of glucocorticoids are mediated, in part, by 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), which amplifies their effects at the pre-receptor level by converting cortisone to cortisol. Glucocorticoids, such as dexamethasone, inhibit vascular smooth muscle cell proliferation; however, the role of 11β-HSD1 in this response remains unknown. Accordingly, we treated human coronary artery smooth muscle cells (HCSMC) with dexamethasone (10(-9)-10(-6) mol/l) and found that after 72 h dexamethasone increased 11β-HSD1 expression (14.16 ± 1.6-fold, P < 0.001) and activity (6.21 ± 1.2-fold, P < 0.001) in a dose- and time-dependent manner, which was dependent upon glucocorticoid receptor (GR) activation and C/EBPβ and C/EBPδ signaling. As glucocorticoids are known to negatively regulate GR expression, we examined the effect of decreasing 11β-HSD1 expression on GR expression. In HCSMC transfected with 11β-HSD1 siRNA, GR expression was increased; this effect was associated with protein kinase A activation and CREB phosphorylation. To examine the role of 11β-HSD1 in HCSMC proliferation, we decreased 11β-HSD1 expression and stimulated cells with platelet-derived growth factor (PDGF) (10 ng/ml). Decreased 11β-HSD1 expression was associated with increased cell proliferation in the absence of PDGF compared to scrambled control-transfected cells (236.10 ± 13.11%, n = 4, P < 0.001) and this effect was augmented by PDGF. Furthermore, the inhibitory effect of dexamethasone on cellular proliferation was abrogated in 11β-HSD1 siRNA-transfected HCSMC. Downregulation of 11β-HSD1 was associated with decreased p27(kip1) expression and increased phosphorylated retinoblastoma protein, consistent with a proliferative response. These findings suggest that 11β-HSD1 plays a role in the effects of glucocorticoids on vascular smooth muscle cell phenotype.

摘要

糖皮质激素的作用部分是通过 11β-羟类固醇脱氢酶 1(11β-HSD1)介导的,它通过将可的松转化为皮质醇在受体前水平放大其作用。例如地塞米松等糖皮质激素可抑制血管平滑肌细胞增殖;然而,11β-HSD1 在这种反应中的作用尚不清楚。因此,我们用地塞米松(10(-9)-10(-6)mol/l)处理人冠状动脉平滑肌细胞(HCSMC),发现 72 小时后地塞米松以剂量和时间依赖的方式增加了 11β-HSD1 的表达(增加 14.16 ± 1.6 倍,P < 0.001)和活性(增加 6.21 ± 1.2 倍,P < 0.001),这依赖于糖皮质激素受体(GR)的激活和 C/EBPβ 和 C/EBPδ 信号。由于已知糖皮质激素可负调节 GR 的表达,我们研究了降低 11β-HSD1 表达对 GR 表达的影响。在转染 11β-HSD1 siRNA 的 HCSMC 中,GR 表达增加;这种作用与蛋白激酶 A 激活和 CREB 磷酸化有关。为了研究 11β-HSD1 在 HCSMC 增殖中的作用,我们降低了 11β-HSD1 的表达并用血小板衍生生长因子(PDGF)(10ng/ml)刺激细胞。与转染 scrambled 对照 siRNA 的细胞相比,降低 11β-HSD1 表达后,在没有 PDGF 的情况下细胞增殖增加(增加 236.10 ± 13.11%,n = 4,P < 0.001),且这种作用被 PDGF 增强。此外,在转染 11β-HSD1 siRNA 的 HCSMC 中,地塞米松对细胞增殖的抑制作用被消除。11β-HSD1 的下调与 p27(kip1)表达的降低和磷酸化视网膜母细胞瘤蛋白的增加有关,这与增殖反应一致。这些发现表明,11β-HSD1 在糖皮质激素对血管平滑肌细胞表型的作用中起作用。

相似文献

3
11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Diabetologia. 2008 Nov;51(11):2003-11. doi: 10.1007/s00125-008-1137-2. Epub 2008 Sep 9.
5
11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Diabetes. 2009 Nov;58(11):2506-15. doi: 10.2337/db09-0525. Epub 2009 Aug 12.
6
Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.
Endocrinology. 2008 Aug;149(8):4069-79. doi: 10.1210/en.2008-0088. Epub 2008 May 8.

引用本文的文献

1
Striatal miR-183-5p inhibits methamphetamine-induced locomotion by regulating glucocorticoid receptor signaling.
Front Pharmacol. 2022 Sep 26;13:997701. doi: 10.3389/fphar.2022.997701. eCollection 2022.
2
Coronary rupture after stent deployment in a patient under chronic immunosuppressive therapy.
J Cardiol Cases. 2012 Aug 11;6(5):e145-e149. doi: 10.1016/j.jccase.2012.07.006. eCollection 2012 Nov.

本文引用的文献

2
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.
Br J Pharmacol. 2009 Mar;156(5):689-712. doi: 10.1111/j.1476-5381.2008.00047.x. Epub 2009 Feb 23.
4
Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Hypertension. 2008 May;51(5):1372-8. doi: 10.1161/HYPERTENSIONAHA.107.105718. Epub 2008 Mar 17.
5
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
Nat Med. 2007 Feb;13(2):189-97. doi: 10.1038/nm1545. Epub 2007 Feb 4.
7
A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent.
Endocrinology. 2006 Jun;147(6):2879-85. doi: 10.1210/en.2005-1621. Epub 2006 Mar 16.
8
Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function.
Cell Mol Life Sci. 2006 Mar;63(5):565-78. doi: 10.1007/s00018-005-5427-2.
10
Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis.
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12165-70. doi: 10.1073/pnas.0500641102. Epub 2005 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验